Literature DB >> 28626250

Association between changes in visual evoked magnetic fields and non-motor features in Parkinson's disease.

Yoshiro Fujisawa1, Tomomi Minato1, Jun-Ichi Uemura1, Minoru Hoshiyama1, Hirohisa Watanabe1, Masaaki Hirayama1.   

Abstract

Visual dysfunction can be caused by several abnormalities, including dysfunctions in the visual cortex and retina. Our aim was to investigate changes in visual evoked brain responses in the primary visual cortex associated with Parkinson's disease (PD). Sixteen healthy control subjects and ten patients with PD participated in this study. We assessed the visual evoked magnetic field (VEF) using magnetoencephalography (MEG). Checkerboard pattern reversal (CPR) and monotonous grating pattern (MGP) stimulations were used. Magnetic resonance imaging (MRI) was performed to analyze brain volume and generate a tractogram. Cognitive and olfactory function, and Unified Parkinson's Disease Rating Scale (UPDRS) scores were evaluated in patients with PD. Four components of the VEF (1M, 2M, 3M, 4M) were observed following stimulation. For both stimuli, results from the 1M and 2M components were significantly greater and the latency of the 1M component was increased markedly in the PD group compared with the healthy control group. In the PD group, 1M latency correlated with the UPDRS score of 1 for both stimuli, and a correlation was observed between olfactory function and the UPDRS score of 3 for the CPR stimulation alone. We suggest that the conduction delay observed following visual stimulation occurs peripherally rather than in the primary visual cortex. Degeneration of selective elements of the visual system in the retina, possibly midget cells, may be involved.

Entities:  

Keywords:  Parkinson’s Disease; Visual Evoked Response; Retina; Olfactory Function

Mesh:

Year:  2017        PMID: 28626250      PMCID: PMC5472540          DOI: 10.18999/nagjms.79.2.147

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  27 in total

1.  Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.

Authors:  Toru Baba; Akio Kikuchi; Kazumi Hirayama; Yoshiyuki Nishio; Yoshiyuki Hosokai; Shigenori Kanno; Takafumi Hasegawa; Naoto Sugeno; Masatoshi Konno; Kyoko Suzuki; Shoki Takahashi; Hiroshi Fukuda; Masashi Aoki; Yasuto Itoyama; Etsuro Mori; Atsushi Takeda
Journal:  Brain       Date:  2012-01       Impact factor: 13.501

2.  Charles Bonnet syndrome and Parkinson's disease.

Authors:  A Alcántara; L Valenciano; A Díaz-Ortuño; M Martínez-Navarro; D Barcía
Journal:  Eur Psychiatry       Date:  1998-11       Impact factor: 5.361

3.  Visual evoked cortical magnetic fields to pattern reversal stimulation.

Authors:  A Nakamura; R Kakigi; M Hoshiyama; S Koyama; Y Kitamura; M Shimojo
Journal:  Brain Res Cogn Brain Res       Date:  1997-07

4.  Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.

Authors:  Yasuaki Mizutani; Tomohiko Nakamura; Akinori Okada; Junichiro Suzuki; Hirohisa Watanabe; Masaaki Hirayama; Gen Sobue
Journal:  Parkinsonism Relat Disord       Date:  2014-02-20       Impact factor: 4.891

5.  Dopaminergic drugs improve human visual contrast sensitivity.

Authors:  L Domenici; C Trimarchi; M Piccolino; A Fiorentini; L Maffei
Journal:  Hum Neurobiol       Date:  1985

6.  Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects.

Authors:  Mutsumi Iijima; Tatsu Kobayakawa; Sachiko Saito; Mikio Osawa; Yukiko Tsutsumi; Shiori Hashimoto; Makoto Iwata
Journal:  Intern Med       Date:  2008-11-04       Impact factor: 1.271

Review 7.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

8.  The effect of intraocular 6-hydroxydopamine on retinal processing of primates.

Authors:  M F Ghilardi; M S Marx; I Bodis-Wollner; C B Camras; A A Glover
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

9.  A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure.

Authors:  M Hirayama; S Hakusui; Y Koike; K Ito; T Kato; M Ikeda; Y Hasegawa; A Takahashi
Journal:  J Auton Nerv Syst       Date:  1995-06-25

10.  Alteration of visual evoked potentials and electroretinograms in Parkinson's disease.

Authors:  I Gottlob; E Schneider; W Heider; W Skrandies
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1987-04
View more
  2 in total

1.  Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease.

Authors:  Ryoji Naganuma; Ichiro Yabe; Megumi Takeuchi; Kirari Morishita; Shingo Nakane; Ryoken Takase; Ikuko Takahashi-Iwata; Masaaki Matsushima; Mika Otsuki; Hideaki Shiraishi; Hidenao Sasaki
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

2.  Apathy and Anhedonia: Clinical and Neurophysiological Assessment of a Romanian Cohort.

Authors:  Diana Sipos-Lascu; Ștefan-Cristian Vesa; Lăcrămioara Perju-Dumbravă
Journal:  Brain Sci       Date:  2021-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.